We used a subclone of a rabbit genomic clone for collagenase that cross-hybridizes with human synovial cell messenger RNA (mRNA) to identify a human collagenase complementary DNA (cDNA) clone. The human cDNA clone is 2.1 kilobases (kb) and selects a mRNA transcript of approximately the same size from primary cultures of rheumatoid synovial cells that produce collagenase, but no mRNA is selected from control (nonproducing) synovial fibroblasts. Restriction enzyme analysis and DNA sequence data indicate that our cDNA clone is full length and that it is identical to that recently described for human skin fibroblast collagenase. The cDNA clone identified a single collagenase gene of 17 kb from blots of human genomic DNA. The identity of human skin and synovial cell collagenase and the ubiquity of this enzyme and of its substrates, the interstitial collagens types I, II, and III, imply that common mechanisms controlling collagenolysis throughout the human body may be operative in both normal and disease states.
Introduction
The neutral proteinase collagenase (E.C. 3.4.23.7) is the only enzyme able to initiate breakdown of the interstitial collagens, types I, II, and III (see reviews [ 1, 2] ). The fact that these collagens are the body's most abundant proteins means that collagenase plays a key role in the remodeling of collagen that occurs constantly in both normal and diseased conditions. Thus, mechanisms concerning the regulation of collagenase both at the level of protein biochemistry and at the level ofthe gene are of prime importance to our understanding of connective tissue metabolism.
Rheumatoid arthritis is a connective tissue disease in which collagenase is a major mediator ofpathology (3) . In rheumatoid arthritis, synovial cells lining the joint proliferate into a huge mass which secretes large quantities of collagenase and invades and destroys cartilage, tendon, and bone. Normally, these cells synthesize and secrete only minimal amounts of collagenase, but in the disease state, they are stimulated by phagocytosis (4), cell fusion (5) , and mediators such as interleukin 1 (6, 7) and crystals of monosodium urate monohydrate (8) to produce large quantities of enzyme. Here we develop and characterize a complementary DNA (cDNA) clone for human synovial cell collagenase. We show that this cDNA clone cross-hybridizes with rabbit collagenase messenger RNA (mRNA) and is identical to a cDNA for human skin collagenase. We further use this cDNA clone to provide data consistent with the existence of a single collagenase gene in the human genome.
Methods
Cell culture. Specimens of rheumatoid synovial tissue, obtained from the operating room of the Mary Hitchcock Hospital (Hanover, NH), were dissociated into a single-cell suspension by sequential treatment with bacterial collagenase and trypsin (9) . Cells were plated at 50% confluency in 100-mm diam culture dishes in 20% fetal calf serum (Gibco, Grand Island, NY). After 7-10 d, when the cells had become confluent, they were washed three times with Hanks' balanced salt solution and placed in serum-free medium supplemented with 0.2% lactalbumin hydrolysate. In some experiments, primary cultures were trypsinized (0.25%; Gibco) and passaged in Dulbecco's modified Eagle's medium with 10% fetal calf serum. At confluence, they were also transferred to serum-free medium. In contrast to primary cultures of rheumatoid synovial cells, these cells do not make collagenase (9) and hence, they served as a negative control. After 24-48 h in serum-free conditions, medium was assayed for collagenase activity in a standard fibril assay with ['4C]collagen fibrils (10) (11) (12) and the RNA was harvested as described previously (13, 14) .
Construction and screening ofa human synovial cell cDNA library for collagenase in bacteriophage X-gtJl. RNA was harvested from primary cultures of rheumatoid synovial cells derived from three individuals. Cells were cultured in serum-free medium and were shown to be synthesizing collagenase by means of the collagen fibril assay (see above). Poly A+ RNA was isolated by oligo dT-cellulose chromatography (13, 15) . 6 jsg of poly A+ RNA served as a template for cDNA synthesis, carried out as described by Gubler and Hoffman (16) . After ligation to linkers containing the Eco RI restriction site, the cDNA was cloned into bacteriophage X-gtl 1, purchased from Promega Biotec (Madison, WI), according to the manufacturer's instructions. A cDNA library containing 1.6 X 104 recombinants was generated and was amplified once.
The library was plated at I04 recombinants per 100-mm diam culture plate and screened for clones containing collagenase sequences by means of in situ plaque hybridization (17) using a rabbit collagenase genomic subclone, p206, known to cross-hybridize with human synovial cell mRNA (18) . Duplicate plaque lifts onto Gene Screen Plus (New England Nuclear, Boston, MA) were made from each plate of recombinants and were probed with p206 insert radiolabeled with 32P by the oligolabeling method ofFeinberg and Vogelstein (19) . Hybridizations were performed exactly as described (20) .
DNA from three-time plaque-purified recombinants was prepared as described (17) . Clone inserts were restriction mapped by single and multiple analysis of the products of restriction enzyme digestions on agarose gels ( 17 (17, 20) . RNA was harvested from rabbit synovial cells that had been induced to synthesize collagenase by treatment with 10-8 M phorbol myristate acetate (13) . The blot was probed first with the hu-col 16 cDNA radiolabeled with 32P by nick translation (17) . The blot was then stripped by boiling for 10' in 0.1 X standard saline citrate and the effectiveness of the stripping procedure was checked by an overnight exposure with XAR-5 film (Eastman Kodak Co., Rochester, NY). It was then probed with rabbit activator cDNA (23), which had been removed in toto from vector with Eco RI and labeled with 32p (19) . Hybridizations were as detailed (17, 20) .
Human genomic DNA for Southern blot analysis was prepared from peripheral blood lymphocytes separated from freshly drawn venous blood by unit gravity sedimentation through dextran/EDTA, following the methods of Aldridge et al. (24) . 10 ,g of each DNA sample was digested overnight at 370C with appropriate enzymes (Boehringer Mannheim, Indianapolis, IN) and run into an 0.8% agarose gel with Tris/borate/ EDTA buffer (17) . The electrophroresis was carried out at 70 V for 4 h at 4VC with recirculation of buffer. Gels were then blotted onto Gene Screen Plus as described for Southern blots. After blotting, they were probed with either the 0.3-kb Eco RI fragment, representing the 5' end of the collagenase cDNA (see below), or the 1.75-kb Eco RI fragment containing the rest ofthe cDNA insert with its 3' end. Probes were labeled by oligolabeling (19) and hybridized (17, 20 (27) . While this work was in progress, the complete sequence of human skin collagenase cDNA was published (28) . The cDNA sequence that we had obtained is identical to that of the skin collagenase except for the first 10 bases at the 5' end ofthe cDNA, which includes most of the direct repeat.
Generation of a restriction map for the human skin sequence and comparison to the restriction map of human synovial cell The primary structure of the putative protein encoded by the cDNA is written under the nucleic acid sequence. A box is drawn around the region that is different from the reported sequence of human skin collagenase (28) and a line is drawn under the direct repeats that probably represent a cloning artifact (32). i-lys-asn-asp-gly-arg-gln-val-glu-lys-arg-arg-asn-ser-gly-pro-val collagenase cDNA also showed no differences. These data strongly suggest that the mRNA for human skin and human synovial cell collagenase were synthesized from the same gene.
Identifcation of human synovial cell collagenase mRNA. When lambda hu-col 16 was used to probe Northern blots, it selected a single mRNA band of 2.2 kb from RNA derived from primary rheumatoid synovial cells that were producing collagenase. No band was selected from RNA from control cultures of human synovial fibroblasts that were not synthesizing collagenase (Fig. 2 A) . Cross-hybridization between rabbit mRNA and human collagenase cDNA was also noted.
Cross-hybridization of rabbit activator cDNA with human mRNA. We have recently isolated a full-length cDNA clone for rabbit activator, a metalloproteinase responsible for the activation of latent rabbit procollagenase (23, (29) (30) (31) . By DNA sequence analysis (29) , rabbit activator shows 77% homology to rat transin, an oncogene transformation-induced protein (32), and it is possible that transin may be the functional equivalent of activator in the rat. To determine whether a similar protein may exist in populations of rheumatoid synovial cells, we first stripped and then reprobed the Northern blot described above with rabbit activator cDNA. Fig. 2 B shows that rabbit activator cDNA hybridized strongly with rabbit mRNA, selecting a band of -1.9 kb. In addition, the cDNA selected a human mRNA, also of 1.9 kb, from primary, collagenase-producing cultures but not from noncollagenase-producing passaged cells. Note that this band is distinct from that detected by the human collagenase cDNA, but that it appears to be coordinately regulated with collagenase mRNA inasmuch as both are present in primary cultures but not in passaged ones.
Detection of the gene for human synovial cell collagenase. Human genomic DNA from 11 individuals, five of whom are members of one family, was digested with a battery ofrestriction enzymes, electrophoresed and blotted, and then probed with the 1.7-and 0.3-kb Eco RI fragments of lambda hu-col 16 cDNA clone. Fig. 3 shows one example ofour studies in which genomic DNA from all 11 individuals was digested with Eco RI and probed with the 1.75-kb fragment of the hu-col 16 cDNA clone.
This probe detected 15-and 1.7-kb fragments in all individuals.
In individual 7, two additional fragments of 1.1 and 0.6 kb were also present. When the blot was probed with the 0.3-kb cDNA fragment, a band of -0.3 kb was detected in all samples (data not shown). In that these bands add up to 17 kb, it is tempting to hypothesize that individual 7 has two collagenase alleles, one with an additional Eco RI site within the 1.7-kb fragment. 
Discussion
Data amassed over the years have supported the concept that human skin and synovial cell collagenase are related enzymes. Synthesis of both can be induced (1) (2) (3) (4) (5) (6) (7) 33) and suppressed (34) (35) (36) by the same compounds. Both have similar molecular weights (28, 37, 38) . Both are secreted as latent forms that are activated by proteinases and organic mercurials and inactivated by nonspecific and specific metalloproteinase inhibitors (1, 2) . Furthermore, recent evidence points to similar if not identical collagenases isolated from a variety of fibroblasts, including corneal (39) , gingival (40), and skin (37, 38) , as well as from several types of endothelial cells, such as brain capillary (41) and umbilical vein (42) . However, these collagenases may be distinct from the neutrophil collagenase (43) and from rat uterine collagenase (44, 45) , which may be under different control mechanisms, and from type IV collagenase which exhibits different substrate specificity (46) . In this article we show, by restriction enzyme analysis and by limited DNA sequence, that there are no differences between synovial cell and skin fibroblast collagenase mRNAs, even in the 5' and 3' untranslated regions where there is less selective pressure for sequence conservation (47) . We believe, therefore, that this constitutes exceedingly solid evidence that the two cDNAs are the product of the same gene.
Of interest is the fact that we have detected a single gene for synovial cell/skin collagenase and that this gene appears to show allelic variation. In the future it will be important to determine whether the collagenase gene in certain individuals with particularly erosive rheumatoid arthritis or individuals with recessive dystrophic epidermolysis bullosa, a disease of the skin in which excess collagenase production is pathologically important (48) , contains restriction fragment length polymorphisms. The confirmation of the identity at the level of nucleic acid of human skin and synovial cell collagenase both solidifies our previous biochemical knowledge and suggests important implications about the ubiquity ofmechanisms regulating connective tissue metabolism throughout the body. Collagenases can be regulated by a variety of mechanisms. First, enzymatic activity of active collagenase can be inhibited by such nonspecific inhibitors of enzymes such as a2-macroglobulin, or by specific inhibitors of metalloproteinases, such as tissue inhibitor of metalloproteinases (TIMP); both are ubiquitous (see reviews [1, 2] ).
A second controlling point for regulation of collagenase activity is in the enzymatic activation of latent procollagenase by another metalloproteinase, proactivator (30, 31) . At least in the rabbit synovial cell system, conversion of procollagenase to an enzymatically active form requires the presence of an activator protein, which is, itself, secreted in latent form. Activation of procollagenase depends, therefore, on a mini-cascade: the sequential activation of proactivator (by enzymes such as trypsin) which then, in turn, activates latent procollagenase. The human analogue ofactivator has not yet been documented although we have detected a 1.9-kb transcript in human synovial cell mRNA probed with rabbit activator cDNA (Fig. 2 B) . In addition, Okada et al. (49) have isolated three metalloproteinases from conditioned culture medium derived from human synovial cells and one or more of these may be candidates for the human activator protein(s).
A final control point for regulation of collagenase activity is at the level of biosynthesis. Synthesis of collagenase can be induced by a variety ofagents, such as interleukin 1 (6, 7) , phorbol esters (13) , crystals of monosodium urate monohydrate (8) or polyethylene glycol which induces giant-cell formation (5) . Conversely, biosynthesis can be antagonized by two classes of compounds, the corticosteroids and the retinoids (34-36), as well as by an autocrine (50). Recent data indicate first, that regulation occurs at the level of mRNA synthesis (13) and second, that activator and collagenase are both coordinately induced and suppressed (23) . Thus we can begin to establish a family of metalloproteinases that appear coordinately regulated and may play a critical role in the modulation of connective tissues.
